ORYZON Announces a New Financing Through a Convertible Bond Program For a Total Amount of Up To €45 Million
Funding provided by Nice & Green SA, a Swiss private investor This CB Program supersedes the previous oneTo extend its cash runway and continue the ongoing clinical trials in CNS and oncology Initial ...